AXSM PEER ANALYSIS

Axsome Therapeutics Inc — metric-by-metric comparison with peers and the industry median

AXSMAxsome Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

AXSMIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	AXSM	CSL	TLX	MSB	Ind. Median
P/E	—	29.44	—	—	17.91
P/B	229.14	2.20●	6.37	—	3.51
EV/EBITDA	—	10.21●	120.14	—	14.82
P/S	17.66	2.62●	3.24	31.61	10.89

Financial Health
Metric	AXSM	CSL	TLX	MSB	Ind. Median
Current Ratio	1.39	2.57●	1.43	—	5.90
Debt/Equity	402.8%	67.4%●	112.3%	—	10.9%
NetDebt/EBITDA	0.49●	2.22	13.13	—	1.15

Profitability
Metric	AXSM	CSL	TLX	MSB	Ind. Median
Net Margin	-26.6%	9.2%●	-0.9%	-115.3%	-125.7%
ROE	-349.4%	7.7%●	-1.8%	-11.3%	-47.5%
ROA	-28.7%	3.8%●	-0.7%	-8.6%	-35.8%
EBITDA Margin	-24.4%	32.8%●	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	AXSM	CSL	TLX	MSB	Ind. Median
Rev. Growth	63.9%	4.8%	56.3%	410.4%●	5.1%
NI Growth	—	-39.4%	—	—	12.1%
Div. Yield	—	2.5%●	—	0.0%	0.2%
Payout	—	103.1%	—	0.0%	0.0%

Valuation
Metric	AXSM	ARWR	IONS	BMRN	KRYS	TECH	Ind. Median
P/E	—	—	—	43.39●	50.85	101.45	17.91
P/B	229.14	19.48	27.24	1.88●	8.96	5.33	3.51
EV/EBITDA	—	—	2.95●	22.55	52.96	43.40	14.82
P/S	17.66	19.23	12.65	3.60●	27.42	9.18	10.89

Financial Health
Metric	AXSM	ARWR	IONS	BMRN	KRYS	TECH	Ind. Median
Current Ratio	1.39	6.23	4.10	5.81	9.46●	4.49	5.90
Debt/Equity	402.8%	223.7%	415.3%	23.2%	0.7%●	13.9%	10.9%
NetDebt/EBITDA	0.49	3.06	0.03	-1.62	-4.06●	0.31	1.15

Profitability
Metric	AXSM	ARWR	IONS	BMRN	KRYS	TECH	Ind. Median
Net Margin	-26.6%	-48.4%	-30.9%	8.3%	53.9%●	9.0%	-125.7%
ROE	-349.4%	-46.4%	-67.5%	4.5%	19.9%●	5.3%	-47.5%
ROA	-28.7%	-15.7%	-10.4%	3.4%	18.2%●	4.2%	-35.8%
EBITDA Margin	-24.4%	-21.6%	433.5%●	14.9%	48.1%	21.3%	-105.8%

Growth + Dividend
Metric	AXSM	ARWR	IONS	BMRN	KRYS	TECH	Ind. Median
Rev. Growth	63.9%●	9.4%	47.5%	9.9%	25.1%	0.2%	5.1%
NI Growth	—	—	—	-48.7%	81.5%●	-16.8%	12.1%
Div. Yield	—	0.3%	0.2%	—	—	0.5%●	0.2%
Payout	—	-13.8%	-6.7%	—	—	45.5%	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on AXSM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.